Cargando…

Biocompatible Peritoneal Dialysis Fluids: Clinical Outcomes

Peritoneal dialysis (PD) is a preferred home dialysis modality and has a number of added advantages including improved initial patient survival and cost effectiveness over haemodialysis. Despite these benefits, uptake of PD remains relatively low, especially in developed countries. Wider implementat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Yeoungjee, Badve, Sunil V., Hawley, Carmel M., Wiggins, Kathryn, Johnson, David W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515903/ https://www.ncbi.nlm.nih.gov/pubmed/23251801 http://dx.doi.org/10.1155/2012/812609

Ejemplares similares

Clinical Causes of Inflammation in Peritoneal Dialysis Patients
por: Cho, Yeoungjee, et al.
Publicado: (2014)

The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study
por: Cho, Yeoungjee, et al.
Publicado: (2012)

Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients
por: Badve, Sunil V., et al.
Publicado: (2009)

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients
por: Cho, Yeoungjee, et al.
Publicado: (2014)

Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases
por: O'Shea, Stacey, et al.
Publicado: (2009)

Longer antibiotic durations for treating peritoneal dialysis-associated peritonitis: helpful or harmful?
por: Htay, Htay, et al.
Publicado: (2021)

Is there such a thing as biocompatible peritoneal dialysis fluid?
por: Schmitt, Claus Peter, et al.
Publicado: (2016)

Peritoneal dialysis fluid biocompatibility impact on human peritoneal membrane permeability
por: Rodríguez-Esparragón, Francisco, et al.
Publicado: (2018)

Epidemiology of peritoneal dialysis outcomes
por: Bello, Aminu K., et al.
Publicado: (2022)

Comparison of Longitudinal Membrane Function in Peritoneal Dialysis Patients According to Dialysis Fluid Biocompatibility
por: van Diepen, A.T.N., et al.
Publicado: (2020)

Incremental Versus Standard (Full-Dose) Peritoneal Dialysis
por: Cheetham, Melissa S., et al.
Publicado: (2021)

Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers?
por: Farhat, Karima, et al.
Publicado: (2008)

Acute hydrothorax complicating peritoneal dialysis: a case report
por: Cho, Yeoungjee, et al.
Publicado: (2010)

Association between causes of peritoneal dialysis technique failure and all-cause mortality
por: Chen, Jenny H. C., et al.
Publicado: (2018)

Rate of decline in residual kidney function pre and post peritoneal dialysis initiation: A post hoc analysis of the IDEAL study
por: Ethier, Isabelle, et al.
Publicado: (2020)

Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry
por: Yang, Wen-ling, et al.
Publicado: (2019)

Burden of kidney failure from atheroembolic disease and association with survival in people receiving dialysis in Australia and New Zealand: a multi-centre registry study
por: Scott, Tahira, et al.
Publicado: (2021)

Biocompatible Peritoneal Dialysis: The Target Is Still Way Off
por: Bartosova, Maria, et al.
Publicado: (2019)

Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS
por: Davies, Simon J., et al.
Publicado: (2020)

Establishing a Core Outcome Measure for Peritoneal Dialysis-related Peritonitis: A Standardized Outcomes in Nephrology—Peritoneal Dialysis Consensus Workshop Report
por: Shen, Jenny I., et al.
Publicado: (2022)

Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution
por: Hamasaki, Yoshifumi, et al.
Publicado: (2014)

The Association between Body Mass Index and Mortality in Incident Dialysis Patients
por: Badve, Sunil V., et al.
Publicado: (2014)

Scope and heterogeneity of outcomes reported in randomized trials in patients receiving peritoneal dialysis
por: Manera, Karine E, et al.
Publicado: (2020)

Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study
por: Wilson, Gregory J., et al.
Publicado: (2019)

Survival of Peritoneal Membrane Function on Biocompatible Dialysis Solutions in a Peritoneal Dialysis Cohort Assessed by a Novel Test
por: Balafa, Olga, et al.
Publicado: (2021)

Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network
por: Morrish, Alicia T, et al.
Publicado: (2014)

End-stage kidney disease due to haemolytic uraemic syndrome – outcomes in 241 consecutive ANZDATA registry cases
por: Tang, Wen, et al.
Publicado: (2012)

How to Improve the Biocompatibility of Peritoneal Dialysis Solutions (without Jeopardizing the Patient’s Health)
por: Bonomini, Mario, et al.
Publicado: (2021)

Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload
por: Johnson, David Wayne, et al.
Publicado: (2001)

Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients
por: Waniewski, Jacek, et al.
Publicado: (2016)

Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility
por: Grundström, Gunilla, et al.
Publicado: (2013)

Bioincompatible Impact of Different Peritoneal Dialysis Fluid Components and Therapeutic Interventions as Tested in a Rat Peritoneal Dialysis Model
por: Stavenuiter, Andrea W. D., et al.
Publicado: (2011)

Effects of prophylactic antibiotics before peritoneal dialysis catheter implantation on the clinical outcomes of peritoneal dialysis patients
por: Liu, Xihui, et al.
Publicado: (2019)

Cytotoxic Glucose Degradation Products in Fluids for Peritoneal Dialysis
por: Adib, Noushin, et al.
Publicado: (2011)

Compatibility of aztreonam in four commercial peritoneal dialysis fluids
por: Tobudic, Selma, et al.
Publicado: (2020)

Obesity, Weight Gain, and Fluid Overload in Peritoneal Dialysis
por: Ng, Jack Kit-Chung, et al.
Publicado: (2022)

The outcomes of patients with kidney failure due to focal segmental glomerulosclerosis (FSGS) in Australia and New Zealand: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)
por: Bose, Bhadran, et al.
Publicado: (2023)

Microbial Profile, Peritoneal Fluid White Blood Cell Count, and Outcome of Peritoneal Dialysis-Related Peritonitis at Indonesian Tertiary Hospital
por: Solin, Ro Shinta Christina, et al.
Publicado: (2023)

Optimal peritoneal fluid white blood cell count for diagnosis of peritonitis in peritoneal dialysis patients
por: Kunin, Margarita, et al.
Publicado: (2023)

Biocompatibility of peritoneal dialysis solutions determined by genomics of human leucocytes: a cross-over study
por: Wilflingseder, Julia, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_t5u88j41d5i801qag30kh5dal8